Cargando…
Monogenetic Forms of Parkinson’s Disease – Bridging the Gap Between Genetics and Biomarkers
The therapy of neurodegenerative diseases such as Parkinson’s disease (PD) is still limited to the treatment of symptoms and primarily aimed at compensating for dopaminergic hypofunction. Numerous disease-modifying therapies currently in the pipeline attempt to modify the underlying pathomechanisms....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934414/ https://www.ncbi.nlm.nih.gov/pubmed/35317530 http://dx.doi.org/10.3389/fnagi.2022.822949 |